Filana Therapeutics
FLNA
145 hedge funds and large institutions have $165M invested in Filana Therapeutics in 2024 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 60 increasing their positions, 23 reducing their positions, and 17 closing their positions.
161% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 23
35% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 17
1% more funds holding
Funds holding: 143 → 145 (+2)
0.91% more ownership
Funds ownership: 26.86% → 27.77% (+0.91%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less call options, than puts
Call options by funds: $24.4M | Put options by funds: $28.4M
30% less capital invested
Capital invested by funds: $236M → $165M (-$71.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$14.2M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.89M |
| 3 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$4.6M |
| 4 |
BlackRock
New York
|
+$3.67M |
| 5 |
Capital Fund Management (CFM)
Paris,
France
|
+$2.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
-$1.1M |
| 2 |
Morgan Stanley
New York
|
-$866K |
| 3 |
SC
Sculptor Capital
New York
|
-$655K |
| 4 |
Barclays
London,
United Kingdom
|
-$634K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$602K |
FLNA Hedge Fund Activity: Q2 2024 in Review
145 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q2 2024, worth a combined $165M — down 30% from $236M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new FLNA positions and 17 closed out — a net gain of 6 holders — while 60 added to existing stakes and 23 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $14.2M. The largest seller was Norges Bank, cutting an estimated $1.1M.
- 145 institutional investors held Filana Therapeutics (FLNA) as of Q2 2024, up from 143 in Q1 2024.
- Funds reported $165M of Filana Therapeutics stock for Q2 2024, down 30% quarter-over-quarter.
- 23 funds opened new Filana Therapeutics positions in Q2 2024 and 17 closed out, a net change of +6 holders.
- The largest Filana Therapeutics buyer in Q2 2024 was Susquehanna International Group, an estimated $14.2M added.
- The largest Filana Therapeutics seller in Q2 2024 was Norges Bank, an estimated $1.1M sold.
Based on aggregated 13F filings for Q2 2024.